Replimune Group Inc
Replimune Group Inc (REPL) Implied Volatility Current
REPL implied volatility is 88%. IV Rank is 7%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking REPL implied volatility helps you identify when options premiums on Replimune Group Inc are historically cheap or expensive, and where the best trades are hiding. Replimune Group Inc implied volatility reflects the market's expectation of future price movement: when REPL IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Replimune Group Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For REPL, tracking metrics like REPL IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on REPL signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells.
Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where REPL implied volatility sits today versus where it has been. Our scanner ranks Replimune Group Inc implied volatility against its historical range, surfaces extremes in REPL IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Replimune Group Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 16, 2026
Trade options with IV on your side
Track REPL IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→